News & Articles

Harvard, MIT, and various teaching hospitals team up with industry partners to launch new center for regenerative therapies

The Ziath range of CryzoTraq™ 2D-barcoded tubes aims to set a new standard for cryogenic storage of biological specimens at temperatures as low as -196°C

Clinical trial will evaluate the safety and immunogenicity of Entervax™

Distinguished speaker Dr. Bruce Levine addresses some of the current healthcare challenges that impact the development of new therapies

Proximity will facilitate local and international sponsor access to Kayentis’ eCOA services for mid- to later-stage clinical trials

LG Chem selects second and third drug targets following rapid progress in first program

Zelluna Immunotherapy presented data on its lead compound ZI-H04 at the Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Promega enters global collaboration with Merck to develop Microsatellite Instability (MSI) companion diagnostic for use with KEYTRUDA®

Lead allosteric PLK1 inhibitor to progress through preclinical and IND enabling studies

Thermo Fisher Scientific's forum focuses on strategies to expedite biotherapeutic development and commercialization

New technique could enable assembly of circuit boards and displays with more minute components

New collaboration to focus on developing potent Affimer-drug conjugates

Incorporation of AI technologies highlights the most accurate compound predictions to enable effective project decision-making

Designed specifically for smaller biobanks the BB package simplifies sample integrity, tracking and audit trail.

SelectScience is heading to Chicago, USA, to interview scientists at the forefront of neuroscience research and report on the latest techniques and technologies advancing the field

AstraZeneca BioPharmaceuticals R&D has invested in a LyoConstellationTM S10 freeze dryer intended to help drive research and development of small scale GMP production.

Study done at the University of Cambridge suggests a way to predict prognosis and most effective treatment in cancer

Roche's Tecentriq improves overall survival as a first-line monotherapy in certain people with advanced non-small cell lung cancer

Women with a rare type of ovarian cancer could benefit from a drug that quadruples the likelihood of response compared with standard therapies

Cloud-based solution automates NGS data analysis for liquid biopsy and FFPE workflows

Tell us which new products made the most difference to your lab work and you’ll have the chance to win one of four $500 Amazon gift cards